212 related articles for article (PubMed ID: 1829631)
1. A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen).
Di Minno G; Martinez J; Cirillo F; Cerbone AM; Silver MJ; Colucci M; Margaglione M; Tauro R; Semeraro N; Quattrone A
Arterioscler Thromb; 1991; 11(4):785-96. PubMed ID: 1829631
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
[TBL] [Abstract][Full Text] [Related]
4. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
[TBL] [Abstract][Full Text] [Related]
6. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Chapel Hill II: defective in reactions with thrombin, factor XIIIa and plasmin.
Carrell N; McDonagh J
Br J Haematol; 1982 Sep; 52(1):35-47. PubMed ID: 6126210
[TBL] [Abstract][Full Text] [Related]
8. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
[TBL] [Abstract][Full Text] [Related]
9. Analysis of fibrin formation and proteolysis during intravenous administration of ancrod.
Dempfle CE; Argiriou S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
Blood; 2000 Oct; 96(8):2793-802. PubMed ID: 11023513
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization.
Steinmann C; Reber P; Jungo M; Lämmle B; Heinemann G; Wermuth B; Furlan M
Blood; 1993 Oct; 82(7):2104-8. PubMed ID: 8400260
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia.
Fernández FJ; Rodríguez Pinto C; Páramo J; Cuesta B; Collado M; Rocha E
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):571-5. PubMed ID: 2133236
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
Lee MH; Kaczmarek E; Chin DT; Oda A; McIntosh S; Bauer KA; Clyne LP; McDonagh J
Blood; 1991 Oct; 78(7):1744-52. PubMed ID: 1912564
[TBL] [Abstract][Full Text] [Related]
15. Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: effect of the A alpha 16 Arg leads to His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide.
Lane DA; Southan C; Ireland H; Thompson E; Kehl M; Henschen A
Br J Haematol; 1983 Apr; 53(4):587-97. PubMed ID: 6830702
[TBL] [Abstract][Full Text] [Related]
16. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism.
Mullin JL; Gorkun OV; Lord ST
Biochemistry; 2000 Aug; 39(32):9843-9. PubMed ID: 10933802
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen proteolysis by thrombin, plasmin and platelet release in relation to disseminated intravascular coagulation.
Nossel HL
Bibl Haematol; 1983; (49):151-62. PubMed ID: 6230075
[No Abstract] [Full Text] [Related]
18. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the thrombin-platelet reactions by DuP 714.
Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
[TBL] [Abstract][Full Text] [Related]
20. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
Peerschke EI
Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
